Global pharmaceutical and life sciences giant Bayer AG is currently negotiating thousands of US lawsuits claiming that the company’s glyphosate-based Roundup grass and weed killer causes a type of cancer called non-Hodgkin’s lymphoma.

Complications from the coronavirus have been added to a list of issues for which school districts and parents of nicotine-addicted teens are seeking damages from Juul Labs Inc. and other companies in the vape industry.

While facing a sharp drop in new car wreck cases, Baton Rouge personal injury attorneys are beginning to field a smattering of inquiries about coronavirus-related litigation.

One may not need to be able to read the cannabis leaves to divine the impact of the COVID-19 pandemic on cannabis and insurance. Some good guesses from any insurance professional with their foot in the door of a dispensary, farm, lab, or distribution facility, might go along the lines of: Vaping will be tougher to insure, reinsurance will be harder to find, expect even more exclusions in policies, greater capacity.

A few weeks ago, Hilary Bricken wrote about the proliferation of ketamine clinics in the United States and the logistics and legalities of operating a ketamine infusion clinic. As Hilary explained, the only FDA approved use of ketamine is for the induction and maintenance of anesthesia, though it also used for off-label infusions in the management of psychiatric disorders and chronic pain management.

If you felt a disturbance in the force this morning, you weren’t alone. Early this a.m., an allegedly stolen Gemballa Mirage GT was used to smash into several parked cars in the Hell’s Kitchen neighborhood of New York City before finally coming to a crumpled halt just past the Javits center.

The family of a Walmart Inc employee in Illinois who died after contracting COVID-19, the illness caused by the novel coronavirus, has filed a lawsuit accusing the retail giant of failing to adequately screen and protect workers.

Four months ago, Pacific Gas & Electric seemed poised to emerge from bankruptcy after reaching a $13.5 billion settlement with tens of thousands of people who lost homes in wildfires started by the utility’s equipment.

The precautions underway to reduce COVID-19 transmission risk appear to be having a direct impact on auto accident benefits claimants - and not in a good way.

Insurers are bracing themselves for billions of dollars of claims because of legal action over the coronavirus pandemic.

As we grapple with the human and personal effects of COVID-19, the pandemic is forcing companies to closely examine their corporate insurance programs to determine where, if at all, coverage can provide some relief to the economic losses that COVID-19 will cause.

It is an election year, which means from now until the polls close in November, politics will be a big topic of discussion. With key electoral events every month of 2020 including caucuses, debates, and elections, and with news and social-media coverage of the same, employers should expect political discussions to find their way into the workplace.

Insurers are increasingly worried about shareholders, employees or customers bringing coronavirus-related claims against company executives and are considering excluding the virus from policies which protect the bosses, industry sources say.

As South Florida media reported on empty supermarket shelves because of COVID-19 panic-buying, some personal injury attorneys say they saw a spike in car accident cases.

Government regulators and agencies are vested with increasingly significant powers to investigate—and potentially prosecute—companies and individuals suspected of wrongdoing. Such investigations are fraught with insurance implications, including, critically, whether and when such an investigation constitutes a claim under an insured’s professional liability policy, thereby triggering a carrier’s defense obligations.